NO20081723L - Assosiasjon av beta 3 reseotoragonist og monoamin gjenopptaksinhibator, farmasoytisk sammensetting inneholdende samme og terapeutisk anvendelse derav - Google Patents
Assosiasjon av beta 3 reseotoragonist og monoamin gjenopptaksinhibator, farmasoytisk sammensetting inneholdende samme og terapeutisk anvendelse deravInfo
- Publication number
- NO20081723L NO20081723L NO20081723A NO20081723A NO20081723L NO 20081723 L NO20081723 L NO 20081723L NO 20081723 A NO20081723 A NO 20081723A NO 20081723 A NO20081723 A NO 20081723A NO 20081723 L NO20081723 L NO 20081723L
- Authority
- NO
- Norway
- Prior art keywords
- association
- agonist
- pharmaceutical composition
- reseotor
- therapeutic use
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/136—Amines having aromatic rings, e.g. ketamine, nortriptyline having the amino group directly attached to the aromatic ring, e.g. benzeneamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det beskrives assosiasjonen av minst én ß3 adrenergisk reseptoragonist (eller ß3 agonist) (I) med en monoamingjenopptaksinhibitor. Det beskrives videre et farmasøytisk preparat omfattende oppfinnelsens assosiasjon og dennes terapeutiske anvendelse.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0509528A FR2890862B1 (fr) | 2005-09-19 | 2005-09-19 | Association d'agoniste aux recepteurs beta 3 et d'inhibiteur de la recapture de monoamnies, compostion pharmaceutique la contenant et son utilisation en therapeutique. |
PCT/FR2006/002125 WO2007034056A1 (fr) | 2005-09-19 | 2006-09-18 | ASSOCIATION D'AGONISTE AUX RECEPTEURS ß3 ET D'INHIBITEURS DE LA RECAPTURE DE MONOAMINES, COMPOSITION PHARMACEUTIQUE LA CONTENANT ET SON UTILISATION EN THERAPEUTIQUE |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081723L true NO20081723L (no) | 2008-05-29 |
Family
ID=36384391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081723A NO20081723L (no) | 2005-09-19 | 2008-04-07 | Assosiasjon av beta 3 reseotoragonist og monoamin gjenopptaksinhibator, farmasoytisk sammensetting inneholdende samme og terapeutisk anvendelse derav |
Country Status (23)
Country | Link |
---|---|
US (1) | US20080182899A1 (no) |
EP (1) | EP1928448B1 (no) |
JP (1) | JP2009508829A (no) |
KR (1) | KR20080064115A (no) |
CN (1) | CN101267814A (no) |
AR (1) | AR055436A1 (no) |
AT (1) | ATE441407T1 (no) |
AU (1) | AU2006293801A1 (no) |
BR (1) | BRPI0616197A2 (no) |
CA (1) | CA2620235A1 (no) |
CR (1) | CR9768A (no) |
DE (1) | DE602006008964D1 (no) |
EA (1) | EA200800870A1 (no) |
EC (1) | ECSP088275A (no) |
FR (1) | FR2890862B1 (no) |
IL (1) | IL189755A0 (no) |
MA (1) | MA30002B1 (no) |
NO (1) | NO20081723L (no) |
NZ (1) | NZ566310A (no) |
TN (1) | TNSN08095A1 (no) |
TW (1) | TW200744571A (no) |
WO (1) | WO2007034056A1 (no) |
ZA (1) | ZA200802544B (no) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4018895A (en) * | 1974-01-10 | 1977-04-19 | Eli Lilly And Company | Aryloxyphenylpropylamines in treating depression |
FR2669821A1 (fr) * | 1990-12-04 | 1992-06-05 | Sanofi Sa | Utilisation de phenylethanolaminotetralines pour la preparation de medicaments destines au traitement de la depression. |
US5288749A (en) * | 1991-12-20 | 1994-02-22 | Abbott Laboratories | Tertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitors |
US6288749B1 (en) * | 1996-11-16 | 2001-09-11 | Altec Lansing Technologies, Inc. | Computer system with remote television display |
SE9703375D0 (sv) * | 1997-09-18 | 1997-09-18 | Astra Ab | A new combination |
FR2826651B1 (fr) * | 2001-06-28 | 2005-09-02 | Sanofi Synthelabo | Forme cristalline d'une phenylethanolamine, sa preparation et compositions pharmaceutiques la contenant |
JP2007505095A (ja) * | 2003-09-12 | 2007-03-08 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | うつ病及び不安障害の治療のためのアルファ−2−デルタリガンド及びssri及び/又はsnriを含む組み合わせ |
-
2005
- 2005-09-19 FR FR0509528A patent/FR2890862B1/fr not_active Expired - Fee Related
-
2006
- 2006-09-13 TW TW095133911A patent/TW200744571A/zh unknown
- 2006-09-15 AR ARP060104041A patent/AR055436A1/es unknown
- 2006-09-18 CA CA002620235A patent/CA2620235A1/fr not_active Abandoned
- 2006-09-18 EP EP06808148A patent/EP1928448B1/fr active Active
- 2006-09-18 EA EA200800870A patent/EA200800870A1/ru unknown
- 2006-09-18 CN CNA2006800343240A patent/CN101267814A/zh active Pending
- 2006-09-18 AU AU2006293801A patent/AU2006293801A1/en not_active Abandoned
- 2006-09-18 AT AT06808148T patent/ATE441407T1/de not_active IP Right Cessation
- 2006-09-18 ZA ZA200802544A patent/ZA200802544B/xx unknown
- 2006-09-18 NZ NZ566310A patent/NZ566310A/en unknown
- 2006-09-18 JP JP2008530571A patent/JP2009508829A/ja not_active Withdrawn
- 2006-09-18 WO PCT/FR2006/002125 patent/WO2007034056A1/fr active Application Filing
- 2006-09-18 BR BRPI0616197-9A patent/BRPI0616197A2/pt not_active IP Right Cessation
- 2006-09-18 KR KR1020087006585A patent/KR20080064115A/ko not_active Application Discontinuation
- 2006-09-18 DE DE602006008964T patent/DE602006008964D1/de active Active
-
2008
- 2008-02-25 IL IL189755A patent/IL189755A0/en unknown
- 2008-02-26 CR CR9768A patent/CR9768A/es not_active Application Discontinuation
- 2008-02-28 TN TNP2008000095A patent/TNSN08095A1/en unknown
- 2008-03-14 EC EC2008008275A patent/ECSP088275A/es unknown
- 2008-03-18 US US12/050,557 patent/US20080182899A1/en not_active Abandoned
- 2008-04-07 NO NO20081723A patent/NO20081723L/no not_active Application Discontinuation
- 2008-04-14 MA MA30838A patent/MA30002B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
TNSN08095A1 (en) | 2009-07-14 |
US20080182899A1 (en) | 2008-07-31 |
CA2620235A1 (fr) | 2007-03-29 |
FR2890862A1 (fr) | 2007-03-23 |
DE602006008964D1 (de) | 2009-10-15 |
ECSP088275A (es) | 2008-04-28 |
TW200744571A (en) | 2007-12-16 |
ATE441407T1 (de) | 2009-09-15 |
CN101267814A (zh) | 2008-09-17 |
AR055436A1 (es) | 2007-08-22 |
KR20080064115A (ko) | 2008-07-08 |
WO2007034056A1 (fr) | 2007-03-29 |
MA30002B1 (fr) | 2008-12-01 |
BRPI0616197A2 (pt) | 2011-06-14 |
JP2009508829A (ja) | 2009-03-05 |
IL189755A0 (en) | 2008-12-29 |
CR9768A (es) | 2008-09-23 |
EA200800870A1 (ru) | 2008-08-29 |
EP1928448A1 (fr) | 2008-06-11 |
EP1928448B1 (fr) | 2009-09-02 |
AU2006293801A1 (en) | 2007-03-29 |
ZA200802544B (en) | 2009-08-26 |
NZ566310A (en) | 2010-03-26 |
FR2890862B1 (fr) | 2008-01-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1113159T1 (el) | Ανταγωνιστες υποδοχεα γλυκαγονης, παρασκευη και θεραπευτικες χρησεις | |
DK3219705T3 (da) | Farmaceutiske sammensætninger af den amorfe form af n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinolin-3-carboxamid | |
BRPI0606256A2 (pt) | inibidores da enzima 11-beta-hidroxiesteróide desidrogenase tipo i, uso e composição farmacêutica compreendendo os mesmos | |
BRPI0413563A (pt) | compostos e composições como inibidores de atividade do receptor de quìnase de tirosina | |
NO20063620L (no) | Arylanilinderivater som beta2 adrenergiske receptoragonister | |
NO20091700L (no) | Florizinanaloger som inhibitorer av glukose-ko-transporter 2 | |
NO20053965L (no) | Fremgangsmate for fremstilling av belagt preparat | |
ATE526318T1 (de) | Farnesoid-x-rezeptor-agonisten | |
ECSP077401A (es) | Medicamentos que contienen compuestos de carbonilo y su uso | |
AU2009303758A8 (en) | Benzoquinoline inhibitors of vesicular monoamine transporter 2 | |
ATE390922T1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
DK1506185T3 (da) | Forbindelser og deres anvendelse som 5-HT-inhibitorer | |
CL2007002578A1 (es) | Compuestos derivados de n-(1-ftalazin-1-il-piperidin-4-il)-amidas; composicion farmaceutica; y uso para el tratamiento y prevencion de trastornos de la fertilidad, osteoporosis y cancer. | |
CY1118976T1 (el) | Κρυσταλλικες τροποποιησεις της (1r,2r)-3-(3-διμεθυλαμινο-1-αιθυλ-2-μεθυλ-προπυλ)-φαινολης | |
CL2007000595A1 (es) | Compuestos derivados de piperidina; composicion farmaceutica y uso para el tratamiento y/o profilaxis de enfermedades seleccionadas entre hipertension, insuficiencia cardiaca congestiva e insuficiencia renal entre otras. | |
NO20072005L (no) | Nye heterocykliske amider | |
BR0315346A (pt) | Método para o tratamento ou prevenção de sintomas de vasomotores em um paciente, formulação farmacêutica e utilização de inibidor de re-apreensão de norepinefrina em combinação com antagonista de 5-h2a | |
SV2005001805A (es) | 3-aminopirrolidinas como inhibidores de la captacion de monoamina ref. x-15735 | |
UY29712A1 (es) | Sal de derivado de piperidina, composición farmacéutica que la contiene y aplicaciones | |
EA200801139A1 (ru) | Композиция для аэрозольной ингаляции | |
NO20081723L (no) | Assosiasjon av beta 3 reseotoragonist og monoamin gjenopptaksinhibator, farmasoytisk sammensetting inneholdende samme og terapeutisk anvendelse derav | |
CL2007003396A1 (es) | Uso de agomelatina o n-[2-(7-metoxi-1-naftil)etil]acetamida para el tratamiento del sindrome de smith magenis; composicion farmaceutica que contiene agomelatina. | |
GT200600141A (es) | Utilización de agomelatina para la obtención de medicamentos destinados al tratamiento de trastornos bipolares | |
MY142260A (en) | New association of agomelatine and a noradrenaline reuptake inhibitor, and pharmaceutical compositions containing them | |
UY29713A1 (es) | Sal de derivado de piperidina, composición farmacéutica que la contiene y aplicaciones |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |